NZMS Diabetes is excited to announce the powerful and revolutionary Dexcom G6 Continuous Glucose Monitoring System (CGM) will be available in New Zealand for people with diabetes ages 2 years and up from Monday 11 May 2020.

  “The Dexcom G6 represents the future of diabetes management. Not only does the product eliminate the need for fingerpricks, but it provides real time glucose data that empowers people with diabetes to better control their condition and live healthier lives,” said Paul Flynn, general manager for Americas and Asia Pacific at Dexcom.

New with Dexcom G6:

Dexcom G6 carries forward important features of current Dexcom CGM systems:

·                Continuous Glucose Readings – Automatically sends glucose readings to a Dexcom receiver or compatible smart device every five minutes.

·                Mobile App and Sharing – Compatibility with smart device apps allows for sharing glucose information with up to five people for added support.

·                Customisable Alarms and Alerts – Personalised alert schedule immediately warns the wearer of pending dangerous high and low blood sugars.

More details, including pricing options are available on the NZMS Diabetes website. For any questions please contact nzms@nzms.co.nz

*If your glucose alerts and readings from the G6 do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. G6 readings can be used to make diabetes treatment decisions when taking up to a maximum acetaminophen dose of 1,000mg every six hours. Taking a higher dose may affect the G6 readings. To view a list of compatible devices, visit www.dexcom.com/compatibility